tiprankstipranks
Arterra Bioscience SpA (IT:ARBS)
:ARBS
Italy Market
ARBS
Arterra Bioscience SpA
RESEARCH TOOLSreports

Arterra Bioscience SpA (ARBS) Ratios

0 Followers

Arterra Bioscience SpA Ratios

IT:ARBS's free cash flow for Q4 2025 was €0.13. For the 2025 fiscal year, IT:ARBS's free cash flow was decreased by € and operating cash flow was €0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 7.74 7.74 9.99 9.35 8.49
Quick Ratio
 5.99 5.99 8.37 7.74 7.49
Cash Ratio
 1.52 1.52 4.06 4.37 3.80
Solvency Ratio
 1.14 1.14 0.85 0.89 0.93
Operating Cash Flow Ratio
 2.26 2.26 1.29 1.22 1.21
Short-Term Operating Cash Flow Coverage
 21.32 21.32 11.04 11.88 8.01
Net Current Asset Value
€ 4.82M€ 4.82M€ 6.25M€ 6.08M€ 7.70M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.03 0.03 0.04
Debt-to-Equity Ratio
 0.02 0.02 0.03 0.04 0.05
Debt-to-Capital Ratio
 0.02 0.02 0.03 0.03 0.04
Long-Term Debt-to-Capital Ratio
 0.01 0.01 0.02 0.03 0.03
Financial Leverage Ratio
 1.16 1.16 1.17 1.17 1.20
Debt Service Coverage Ratio
 16.63 9.44 17.17 16.80 10.74
Interest Coverage Ratio
 667.15 667.15 1.08K -35.56 48.60
Debt to Market Cap
 0.01 0.01 0.03 0.03 0.03
Interest Debt Per Share
 0.04 0.04 0.05 0.06 0.07
Net Debt to EBITDA
 -0.69 -1.23 -1.46 -1.79 -1.67
Profitability Margins
Gross Profit Margin
15.87%15.87%87.46%55.46%13.72%
EBIT Margin
27.32%12.73%40.81%39.33%50.26%
EBITDA Margin
33.56%18.97%48.94%55.29%65.07%
Operating Profit Margin
12.73%12.73%35.19%-10.69%10.16%
Pretax Profit Margin
42.97%42.97%40.77%39.03%50.05%
Net Profit Margin
43.15%43.15%32.03%32.26%39.38%
Continuous Operations Profit Margin
43.15%43.15%32.03%32.26%39.38%
Net Income Per EBT
100.43%100.43%78.56%82.64%78.67%
EBT Per EBIT
337.60%337.60%115.85%-365.28%492.41%
Return on Assets (ROA)
13.75%13.75%9.97%8.57%11.25%
Return on Equity (ROE)
16.55%15.95%11.70%10.01%13.51%
Return on Capital Employed (ROCE)
4.32%4.32%11.68%-3.04%3.20%
Return on Invested Capital (ROIC)
4.29%4.29%9.10%-2.50%2.48%
Return on Tangible Assets
13.77%13.77%10.00%8.60%11.29%
Earnings Yield
10.61%9.98%10.24%9.74%9.83%
Efficiency Ratios
Receivables Turnover
 1.33 1.33 1.29 1.66 1.35
Payables Turnover
 16.26 16.26 1.90 5.95 16.35
Inventory Turnover
 2.54 2.54 0.39 1.10 2.65
Fixed Asset Turnover
 2.77 2.77 2.77 2.71 2.34
Asset Turnover
 0.32 0.32 0.31 0.27 0.29
Working Capital Turnover Ratio
 0.69 0.70 0.58 0.43 0.44
Cash Conversion Cycle
 395.56 395.56 1.02K 490.96 385.31
Days of Sales Outstanding
 274.42 274.42 282.68 219.28 270.09
Days of Inventory Outstanding
 143.59 143.59 927.83 332.98 137.54
Days of Payables Outstanding
 22.44 22.44 192.19 61.29 22.32
Operating Cycle
 418.01 418.01 1.21K 552.25 407.63
Cash Flow Ratios
Operating Cash Flow Per Share
 0.30 0.30 0.16 0.15 0.21
Free Cash Flow Per Share
 0.23 0.23 0.06 0.14 0.19
CapEx Per Share
 0.07 0.07 0.10 0.01 0.01
Free Cash Flow to Operating Cash Flow
 0.77 0.77 0.38 0.92 0.93
Dividend Paid and CapEx Coverage Ratio
 1.53 1.53 0.80 1.37 3.23
Capital Expenditure Coverage Ratio
 4.40 4.40 1.60 12.40 14.10
Operating Cash Flow Coverage Ratio
 7.65 7.65 2.99 2.66 2.85
Operating Cash Flow to Sales Ratio
 0.43 0.43 0.25 0.31 0.39
Free Cash Flow Yield
8.32%7.65%3.06%8.53%9.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.02 10.02 9.76 10.27 10.17
Price-to-Sales (P/S) Ratio
 4.65 4.32 3.13 3.31 4.00
Price-to-Book (P/B) Ratio
 1.76 1.60 1.14 1.03 1.37
Price-to-Free Cash Flow (P/FCF) Ratio
 14.05 13.07 32.67 11.72 11.09
Price-to-Operating Cash Flow Ratio
 11.10 10.09 12.26 10.77 10.31
Price-to-Earnings Growth (PEG) Ratio
 0.22 0.20 0.39 -0.43 0.43
Price-to-Fair Value
 1.76 1.60 1.14 1.03 1.37
Enterprise Value Multiple
 13.17 21.57 4.93 4.20 4.48
Enterprise Value
 17.42M 19.03M 10.06M 7.75M 10.48M
EV to EBITDA
 11.16 21.57 4.93 4.20 4.48
EV to Sales
 3.75 4.09 2.41 2.32 2.92
EV to Free Cash Flow
 11.32 12.36 25.20 8.22 8.08
EV to Operating Cash Flow
 8.74 9.55 9.46 7.56 7.51
Tangible Book Value Per Share
 1.89 1.89 1.71 1.61 1.56
Shareholders’ Equity Per Share
 1.89 1.89 1.72 1.61 1.57
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 0.21 0.17 0.21
Revenue Per Share
 0.70 0.70 0.63 0.50 0.54
Net Income Per Share
 0.30 0.30 0.20 0.16 0.21
Tax Burden
 1.00 1.00 0.79 0.83 0.79
Interest Burden
 1.57 3.38 1.00 0.99 1.00
Research & Development to Revenue
 0.00 0.00 0.48 0.00 0.46
SG&A to Revenue
 0.03 0.03 0.04 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.99 0.99 0.80 0.95 0.99
Currency in EUR